Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy

Journal of Clinical Oncology

Volumn 20, Issue 5, 2002, Pages 1405-1410

  Adelstein, David J ^a   Saxton, Jerrold P ^a   Lavertu, Pierre ^a   Rybicki, Lisa A ^a   Esclamado, Ramon M ^a   Wood, Benjamin G ^a   Strome, Marshall ^a   Carroll, Marjorie A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG INDUCED DISEASE; DYSPHAGIA; FEBRILE NEUTROPENIA; FEEDING APPARATUS; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LUNG EMBOLISM; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ORGAN PRESERVATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RECURRENT CANCER; SKIN MANIFESTATION; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036498665     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.5.1405     Document Type: Article

References (27)

1. Overview of combined modality therapies for head and neck cancer
2. Treatment of head and neck cancer: The role of chemotherapy
3. Head and neck cancer
4. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
5. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
6. Induction chemotherapy in head and neck cancer
7. Combined effect of xradiation and 5-fluorouracil on survival of transplanted leukemic cells
8. Platinum-radiation interactions
9. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
10. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
11. A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An Intergroup study
12. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
13. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
14. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
15. Altered fractionation trials in head and neck cancer
16. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck
17. Altered fractionation in the treatment of head and neck cancer
18. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
19. Nonparametric estimation of incomplete observations
20. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
21. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
22. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup Trial R91-11
23. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer
24. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
25. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
26. A phase III study of concomitant oral pilocarpine to reduce hypo-salivation and mucositis associated with curative radiation therapy in head and neck cancer patients: RTOG 9709